OBIO
Orchestra BioMed Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Orchestra BioMed Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RTW InvestmentsRTW | $41.2M | 34.47% | +15.05% | |
| 2 | Perceptive AdvisorsPerceptive | $21.7M | 18.17% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $10.8M | 9.06% | +294.89% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $8.7M | 7.30% | −8.23% | |
| 5 | Geode Capital ManagementGeodeindex-like | $4.4M | 3.64% | +107.61% | |
| 6 | Alyeska Investment GroupAlyeska Investment | $4.3M | 3.61% | 0.00% | |
| 7 | Propel Bio ManagementPropel Bio | $3.9M | 3.23% | 0.00% | |
| 8 | UBS Asset Management AmericasUBS Asset Management Americas | $2.8M | 2.32% | new | |
| 9 | State StreetState Streetindex-like | $2.2M | 1.86% | +204.62% | |
| 10 | Rice Hall James & AssociatesRice Hall James & | $1.8M | 1.53% | +2131.46% | |
| 11 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.5M | 1.26% | +31.66% | |
| 12 | Northern TrustNorthern Trustindex-like | $1.5M | 1.24% | +190.55% | |
| 13 | UBS GroupUBS | $1.4M | 1.18% | +547.53% | |
| 14 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.3M | 1.05% | +24.25% | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $1.2M | 0.99% | new | |
| 16 | Knott David M JrKnott David M Jr | $1.1M | 0.91% | 0.00% | |
| 17 | Flat FootedFlat Footed | $1.1M | 0.91% | new | |
| 18 | Simplify Asset ManagementSimplify | $946,655 | 0.79% | 0.00% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $775,000 | 0.65% | +15.69% | |
| 20 | DAFNA Capital ManagementDAFNA | $547,319 | 0.46% | 0.00% | |
| 21 | Renaissance TechnologiesRenaissance Technologies | $388,350 | 0.32% | +26.94% | |
| 22 | IFP AdvisorsIFP | $386,659 | 0.32% | −9.38% | |
| 23 | Daytona Street CapitalDaytona Street Capital | $379,336 | 0.32% | +83.27% | |
| 24 | Bank of New York MellonBank of New York Mellonindex-like | $371,534 | 0.31% | new | |
| 25 | Citadel AdvisorsCitadel | $370,620 | 0.31% | +8.47% |
77 managers report $119.6M of Orchestra BioMed on form 13F for the quarter ended Jun 30 '26. 8 of them hold 80% of it; RTW is largest at 34.47%.
Orchestra BioMed Holdings, Inc.
5.91
−0.18 · −3.00%
post 5.91 0.00%
Largest filed tie
17.00%
of OBIO revenue · Ligand Pharmaceuticals Incorporated ("Ligand")
Fund move
Fund move
Expected move
Inputsstraddle ±22.3%
spot 5.91exp Nov 20ATM strike 5ATM straddle 1.55IV 130%